EP0772599A1 - 2-imidazolidinon-derivate als fungizide - Google Patents

2-imidazolidinon-derivate als fungizide

Info

Publication number
EP0772599A1
EP0772599A1 EP95926914A EP95926914A EP0772599A1 EP 0772599 A1 EP0772599 A1 EP 0772599A1 EP 95926914 A EP95926914 A EP 95926914A EP 95926914 A EP95926914 A EP 95926914A EP 0772599 A1 EP0772599 A1 EP 0772599A1
Authority
EP
European Patent Office
Prior art keywords
carbon atoms
chain
straight
branched
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95926914A
Other languages
German (de)
English (en)
French (fr)
Inventor
Johannes Kanellakopulos
Bernd-Wieland Krüger
Heinz-Wilhelm Dehne
Klaus Stenzel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of EP0772599A1 publication Critical patent/EP0772599A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/38Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< containing the group >N—CO—N< where at least one nitrogen atom is part of a heterocyclic ring; Thio analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms

Definitions

  • the present invention relates to new 2-imidazolidinone derivatives, several processes for their preparation and their use as fungicides.
  • R 1 for alkyl, haloalkyl, alkoxyalkyl, alkenyl, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted phenylalkyl, optionally substituted phenylalkenyl, optionally substituted phenoxyalkyl, optionally substituted
  • Phenylthioalkyl or optionally substituted heterocyclyl R represents alkyl, haloalkyl, alkoxyalkyl, alkenyl, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted phenylalkyl, optionally substituted phenylalkenyl, optionally substituted phenoxyalkyl, optionally substituted phenylthioalkyl or for optionally substituted heterocyclyl and
  • R 4 represents hydrogen, alkyl, haloalkyl, alkoxyalkyl, alkylcarbonyl,
  • R 5 stands for hydrogen, alkyl, haloalkyl, alkoxyalkyl, optionally substituted cycloalkyl, optionally substituted aryl or for optionally substituted heterocyclyl,
  • R 6 represents hydrogen, alkyl, haloalkyl, alkoxyalkyl, alkylcarbonyl,
  • R 7 represents hydrogen, alkyl, haloalkyl, alkoxyalkyl, optionally substituted cycloalkyl, optionally substituted aryl or for optionally substituted heterocyclyl and
  • R represents hydrogen, alkyl, haloalkyl, alkoxyalkyl, optionally substituted cycloalkyl, optionally substituted aryl or for optionally substituted heterocyclyl,
  • R 1 and R 2 have the meanings given above,
  • R 5 has the meanings given above
  • R 7 has the meanings given above
  • R 9 represents alkyl, haloalkyl, alkoxyalkyl, alkylcarbonyl, alkylsulfonyl, haloalkylcarbonyl, alkoxyalkylcarbonyl, optionally substituted cycloalkyl, optionally substituted arylcarbonyl or for optionally substituted arylsulfonyl and
  • Y represents a leaving group
  • R 1 and R 2 have the meanings given above,
  • Z represents a leaving group
  • the compounds according to the invention are generally defined by the formula (I).
  • R 1 is preferably C j -Cg alkyl, C j -C 8 haloalkyl having 1 to 9 halogen atoms, C 1 -C 4 alkoxy-C 1 -C 8 alkyl, C 2 -C 8 alkenyl, for C 3 -C 10 cycloalkyl, where these radicals can be substituted one to six times, identically or differently by halogen, C j -C 4 alkyl and / or C j -C 4 -haloalkyl having 1 to 9 identical or different halogen atoms, phenyl, naphthyl, phenyl-C r C 4 alkyl, phenyl-C 2 -C 4 alkenyl, phenoxy C] -C - alkyl or phenylthio-C 1 -C 4 -alkyl, where each of these radicals can be substituted once to five times, identically or differently by
  • each of the heterocyclic radicals can be monosubstituted to trisubstituted, identical or different, by halogen, cyano, nitro, amino, hydroxyl, formyl, carboxy carbamoyl, thiocarbamoyl, in each case straight-chain or branched alkyl, alkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl each having 1 to 6 Carbon atoms, each straight-chain or branched alkenyl or alkenyloxy each having 2 to 6 carbon atoms, each straight-chain or branched haloalkyl, haloalkoxy, haloalkylthio, haloalkylsulfiny
  • Haloalkenyl or haloalkenyloxy each having 2 to 6 carbon atoms and 1 to 13 identical or different halogen atoms, each straight-chain or branched alkylamino, dialkylamino, alkylcarbonyl, alkylcarbonyloxy, alkoxycarbonyl, alkylsulfonyloxy, hydroximinoalkyl or alkoximinoalkyl each having 1 to 6 carbon atoms in the individual ones Alkyl parts, in each case optionally singly or multiply, identically or differently, each substituted by halogen and / or straight-chain or branched alkyl having 1 to 4 carbon atoms and / or straight-chain or branched haloalkyl having 1 to 4 carbon atoms and 1 to 9 identical or different halogen atoms double linked
  • C j -C 8 alkyl is preferably C j -C 8 alkyl, C j -CG-halogenoalkyl having 1 to 9 Halo ⁇ genatomen, C 1 -C 4 -alkoxy-C 1 -C 8 alkyl, C 2 -C 8 alkenyl, for C 3 -C 10 cycloalkyl, where these radicals can be substituted one to six times, in the same way or differently, by halogen, C ⁇ -C 4 alkyl and / or C 1 -C 4 haloalkyl having 1 to 9 identical or different halogen atoms , for phenyl, naphthyl, phenyl-C r C 4 -alkyl, phenyl-C 2 -C 4 -alkenyl, phenoxy-
  • Carbon atoms in the individual alkyl parts each optionally single or multiple, identical or different by halogen and / or straight-chain or branched alkyl having 1 to 4 carbon atoms and or straight-chain or branched haloalkyl having 1 to 4 carbon atoms and '1 to 9 identical or different Halogen atoms substituted, in each case doubly linked alkylene or dioxyalkylene each having 1 to 6 carbon atoms, cycloalkyl having 3 to 6 carbon atoms, heterocyclyl or heterocyclyl-methyl each having 3 to 7 ring members, of which 1 to 3 are the same or different Heteroatoms are - in particular nitrogen, oxygen and / or sulfur - and in each case in the phenyl part in each case simply to three times, the same or different distinguished by halogen, cyano and / or straight-chain or branched alkyl having 1 to 4 carbon atoms and / or straight-chain or branched haloalkyl having 1 to 4 carbon
  • each of the heterocyclic radicals can be monosubstituted to trisubstituted, identical or different, by halogen, cyano, nitro, amino,
  • R 4 R 6 also preferably stands for the groups - C - N. • - C— N or
  • R 4 preferably represents hydrogen, C 1 -C 6 alkyl; C ] -C 6 haloalkyl having 1 to 9 identical or different halogen atoms;
  • C j -Cg alkyl preferably represents hydrogen; C j -Cg alkyl; C, -C 6 haloalkyl with 1 to 9 identical or different halogen atoms; C, -C 4 -A_koxy-C r C 4 alkyl; for C 3 -C 7 -cycloalkyl, where these radicals can be substituted up to six times, in the same way or differently, by halogen,
  • halogen atoms in each case straight-chain or branched alkylamino, dialkylamino, alkylcarbonyl, alkylcarbonyloxy, alkoxycarbonyl, alkylsulfonyloxy, hydroximinoalkyl or alkoximinoalkyl, each with 1 to 6 carbon atoms in the individual alkyl parts, in each case optionally one or more times, the same or differently substituted by halogen and / or straight-chain or branched alkyl having 1 to 4 carbon atoms and / or straight-chain or branched haloalkyl having 1 to 4 carbon atoms and 1 to 9 identical or different halogen atoms, each having a double bond alkylene or dioxyalkylene, each having 1 to 6 carbon atoms, Cycloalkyl with 3 to 6 carbon atoms, heterocyclyl or heterocyclyl-methyl each with 3 to 7 ring members, of which 1 to 3 are identical or different heteroatoms
  • R also preferably represents optionally benzanellated
  • heterocyclyl with 5 or 6 ring members, at least one of which is oxygen, sulfur or nitrogen and optionally one or two further ring members are nitrogen, in each of which two geminal hydrogen atoms can be replaced by oxygen and each of the heterocyclic groups
  • 15 can be substituted one to three times, in the same way or differently, by halogen, cyano, nitro, amino, hydroxy, formyl, carboxy carbamoyl, thiocarbamoyl, in each case straight-chain or branched alkyl, alkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl each having 1 to 6 carbon atoms, in each case
  • Haloalkenyloxy each having 2 to 6 carbon atoms and 1 to 13 identical or different halogen atoms, each straight-chain or branched alkylamino, dialkylamino, alkylcarbonyl, alkylcarbonyloxy, alkoxycarbonyl, alkylsulfonyloxy, hydroxyl
  • iminoalkyl or alkoximinoalkyl each having 1 to 6 carbon atoms in the individual alkyl parts, each optionally one or more times, identically or differently, by halogen and / or straight-chain or branched alkyl having 1 to 4 carbon atoms and / or straight-chain or branched haloalkyl having 1 to 4th
  • R 6 preferably represents hydrogen, C j -Cg alkyl; C j -C 6 haloalkyl having 1 to 9 identical or different halogen atoms; C 1 -C 4 alkoxy-C 1 -C 4 alkyl; C r C 6 alkyl carbonyl; C r C 6 alkyl sulfonyl; C ⁇ C 8 haloalkyl carbonyl having 1 to 9 identical or different halogen atoms; C 1 -C 4 alkoxy-C ] -C 4 alkylcarbonyl; for C 3 -C 7 -cycloalkyl, where these radicals can be substituted up to six times, identically or differently, by halogen, C, -C 4 -alkyl and / or C 1 -C 4 -haloalkyl having 1 to 9 identical or different halogen atoms , for phenyl carbonyl or phenylsulfonyl, where each of these radicals can be
  • R 7 preferably represents hydrogen; C, -C 6 alkyl; C - C 6 haloalkyl having 1 to 9 identical or different halogen atoms; C ] -C 4 alkoxy-C, -C 4 alkyl; C 3 -C 7 -cycloalkyl, where these radicals may be monosubstituted to hexasubstituted by identical or different halogen, C 1 -C 4 alkyl and / or C j -C 4 -halogenoalkyl having 1 to 9 identical or different halogen atoms , 5 for phenyl or naphthyl, where each of these radicals can be mono- to fivefold, identical or differently substituted by halogen, cyano, nitro, amino, hydroxy, formyl, carboxy carbamoyl, thiocarbamoyl, in each case straight-chain or branched alkyl, alkoxy, alkylthio, alkylsulfinyl
  • each 1 to 6 carbon atoms each straight-chain or branched alkenyl or alkenyloxy each having 2 to 6 carbon atoms, each straight-chain or branched haloalkyl, haloalkoxy, haloalkylthio, haloalkylsulfinyl or haloalkylsulfonyl each of 1 to 6 carbons
  • heterocyclyl-methyl each with 3 to 7 ring members, of which 1 to 3 are identical or different heteroatoms - in particular nitrogen, oxygen and / or sulfur - and in each case in the phenyl part in each case simply to three times, identically or differently by Halogen, cyano and / or straight-chain or mixed
  • each of the heterocyclic radicals can be monosubstituted to trisubstituted, identical or different, by halogen, cyano, nitro, amino, hydroxyl, formyl, carboxycarbamoyl, thiocarbamoyl, in each case straight-chain or branched alkyl, alkoxy, alkylthio, alkylsulfinyl or
  • Alkylsulfonyl each having 1 to 6 carbon atoms, each straight-chain or branched alkenyl or alkenyloxy each having 2 to 6 carbon atoms, each straight-chain or branched haloalkyl, haloalkoxy, haloalkylthio, haloalkylsulfinyl or haloalkylsulfonyl each having 1 to 6 carbon atoms and 1 to 13 the same or different halogen atoms, each straight-chain or branched haloalkenyl or haloalkenyloxy each having 2 to 6 carbon atoms and 1 to 13 identical or different halogen atoms, each straight-chain or branched alkylamino, dialkylamino, alkylcarbonyl,
  • R 8 preferably represents hydrogen; C ] -C 6 alkyl; C j -C 8 haloalkyl having 1 to 9 identical or different halogen atoms;
  • each 1 to 6 carbon atoms each straight-chain or branched alkenyl or alkenyloxy each having 2 to 6 carbon atoms, each straight-chain or branched haloalkyl, haloalkoxy, haloalkylthio, haloalkylsulfinyl or haloalkylsulfonyl each of 1 to 6 carbons
  • each straight-chain or branched haloalkenyl or haloalkenyloxy each having 2 to 6 carbon atoms and 1 to 13 identical or different halogen atoms, each straight-chain or branched alkylamino, dialkylamino, alkylcarbonyl,
  • each of the heterocyclic radicals can be monosubstituted to trisubstituted, identical or different, by halogen, cyano, nitro, amino, hydroxyl, formyl, carboxy carbamoyl, thiocarbamoyl, in each case straight-chain or branched alkyl, alkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl, each having 1 to 1 6 carbon atoms, each straight-chain or branched alkenyl or alkenyloxy each having 2 to 6 carbon atoms, each straight-chain or branched haloalkyl, haloalkoxy, haloalkylthio, haloalkylsul
  • Heterocyclyl-methyl each with 3 to 7 ring members, of which 1 to 3 are identical or different heteroatoms - in particular nitrogen, oxygen and / or sulfur - and in each case optionally in the phenyl part simply to three times, identically or differently by halogen , Cyano and / or straight-chain or branched alkyl with 1 to 4 carbon atoms and / or straight-chain or branched haloalkyl with 1 to 4 carbon atoms and 1 to 9 identical or different halogen atoms and / or straight-chain or branched alkoxy with 1 to 4 carbon atoms and / or straight-chain or branched haloalkoxy with 1 to 4 carbon atoms and 1 to 9 identical or different halogen atoms substituted phenyl, phenoxy, benzyl, benzyloxy, phenylethyl or phenylethyloxy.
  • C j -CG alkyl particularly preferably represents C j -CG alkyl; C-_ 6 haloalkyl having 1 to 9 identical or different halogen atoms; C 1 -C 2 alkoxy-C 1 -C 4 alkyl;
  • 1,3-diyl 1,3-diyl), methylenedioxy or ethylenedioxy, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl, and in each case optionally in the phenyl part in one to three times, identical or different, by fluorine, chlorine, bromine, cyano, methyl, ethyl, n- or i-propyl , n-, i-, s- or t-butyl, trifluoromethyl, methoxy, ethoxy, n- or i-propoxy, difluoromethoxy or
  • C j -C 8 alkyl particularly preferably represents C j -C 8 alkyl; C ⁇ haloalkyl having 1 to 9 identical or different halogen atoms; C 1 -C 2 alkoxy-C 1 -C 4 alkyl;
  • 1,3-diyl 1,3-diyl), methylenedioxy or ethylenedioxy, cyclopropyl, cyclobutyl, Cyclopentyl or cyclohexyl, and in each case optionally in the phenyl part once to three times, identically or differently, by fluorine, chlorine, bromine, cyano, methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, trifluor ⁇ methyl, methoxy, ethoxy, n- or i-propoxy, difluoromethoxy or trifluoromethoxy substituted phenyl, phenoxy, benzyl or benzyloxy.
  • R furthermore particularly preferably represents furyl, tetrahydrofuryl, benzofuryl, tetrahydropyranyl, thienyl, benzothienyl, pyrrolyl, dihydropyrrolyl, tetra- hydropyrrolyl, benzopyrrolyl, Benzodihydropyrrolyl, oxazolyl, benz-oxazolyl, isoxazolyl, thiazolyl, benzothiazolyl, isothiazolyl, imidazolyl, benzimidazolyl, oxadiazolyl, Thiadiazolyl, pyridinyl, pyrimidinyl,
  • R also particularly preferably stands for the groups
  • R 4 particularly preferably represents hydrogen, C j -C. j alkyl; C j -C 4 haloalkyl having 1 to 6 identical or different halogen atoms; C 1 -C 2 alkoxy-C 1 -C 2 alkyl, C r C 4 alkylcarbonyl; C r C 4 alkylsulfonyl, C 1 -C 4 haloalkyl carbonyl with 1 to 6 identical or different
  • Trifluoromethoxy, acetyl, ethylcarbonyl and / or phenyl which itself can be substituted once or twice, identically or differently, by fluorine, chlorine, methyl and / or ethyl.
  • R 5 particularly preferably represents hydrogen, C 1 -C 4 -alkyl; C 1 -C 4 haloalkyl having 1 to 6 identical or different halogen atoms;
  • R 6 particularly preferably represents hydrogen, C j -C 4 alkyl; C 1 -C 4 haloalkyl having 1 to 6 identical or different halogen atoms; C ] -C 2 alkoxy-C 1 -C 2 alkyl, C r C 4 alkylcarbonyl; C r C 4 alkylsulfonyl, C 1 -C 4 haloalkyl carbonyl with 1 to 6 identical or different
  • Trifluoromethoxy, acetyl, ethylcarbonyl and / or phenyl which itself can be substituted once or twice, identically or differently, by fluorine, chlorine, methyl and / or ethyl.
  • R particularly preferably represents hydrogen, C 1 -C 4 -alkyl; C j -C ⁇ haloalkyl having 1 to 6 identical or different halogen atoms;
  • furyl more preferably also stands for furyl, tetrahydrofuryl, benzo colryl, tetrahydropyranyl, thienyl, benzothienyl, pyrrolyl, dihydropyrrolyl, tetrahydropyrrolyl, benzopyrrolyl, benzodihydropyrrolyl, oxazolyl, benzoxazolyl, isoxazolyl, thiazolyl, imiazolyl, imiazolyl, thiazolyl, imiazolyl, thiazolyl, imazolyl,
  • Ethoximinoethyl each up to fourfold, the same as or differently by fluorine, chlorine, methyl, ethyl, n- or i-propyl-substituted trimethylene (propane-l, 3-diyl), methylenedioxy or ethylenedioxy, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl, and in each case, if appropriate, simply in the phenyl part up to three times, identical or different, by fluorine, chlorine, bromine, cyano, methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, trifluoromethyl, methoxy, ethoxy, n- or i- Propoxy, difluoromethoxy or trifluoromethoxy substituted phenyl, phenoxy, benzyl or benzyloxy.
  • R furthermore particularly preferably represents furyl, tetrahydrofuryl, Benzo colryl, tetrahydropyranyl, thienyl, benzothienyl, pyrrolyl, dihydropyrrolyl, tetra- hydropyrrolyl, benzopyrrolyl, Benzodihydropyrrolyl, oxazolyl, benz-oxazolyl, isoxazolyl, thiazolyl, benzothiazolyl, isothiazolyl, imidazolyl, benzimidazolyl, oxadiazolyl, Thiadiazolyl, pyridinyl, pyrimidinyl,
  • R 1 very particularly preferably represents methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, sec-butyl, ter-butyl, n-pentyl, i-pentyl, n-hexyl, i- Hexyl; for chloromethyl, bromomethyl, chloroethyl, bromethyl; for methoxy methyl, methoxyethyl, methoxypropyl, ethoxymethyl,
  • Cyano methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, trifluoromethyl, methoxy, ethoxy, n- or i-propoxy, difluoromethoxy or trifluoromethoxy substituted phenyl, phenoxy , Benzyl or benzyloxy.
  • Cyano methyl, ethyl, n- or i-propyl, n-, i-, s- or t-butyl, trifluoromethyl, methoxy, ethoxy, n- or i-propoxy, difluoromethoxy or trifluoromethoxy substituted phenyl, phenoxy , Benzyl or benzyloxy.
  • R also very particularly preferably stands for the groupings
  • R 4 very particularly preferably represents hydrogen, represents methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, sec-butyl, tert-butyl for chloromethyl, bromomethyl, chloroethyl, bromethyl, chloropropyl, Bromopropyl; for methoxym ethyl, methoxyethyl, ethoxymethyl, ethoxy ethyl; for acetyl, ethylcarbonyl, propylcarbonyl, butyl carbonyl; for methylsulfonyl, ethylsulfonyl, propylsulfonyl, butyl sulfonyl; for acetyl, ethylcarbonyl, propylcarbonyl or butylcarbonyl which is monosubstituted to trisubstituted by fluorine, chlorine and /
  • R 5 very particularly preferably represents hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, sec-butyl, tert-butyl; for chloromethyl, bromomethyl, chloroethyl, bromoethyl, chloropropyl, bromopropyl; for methoxymethyl, methoxy ethyl, ethoxymethyl, ethoxy ethyl; for each optionally one to four times, the same or different by fluorine, chlorine, bromine, methyl, ethyl, n- or i-propyl, chloromethyl
  • R 6 very particularly preferably represents hydrogen, represents methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, sec-butyl, tert.-
  • Residues can be monosubstituted to trisubstituted, identical or different, by fluorine, chlorine, bromine, hydroxy, cyano, nitro, amino, methyl, ethyl, n- or i-propyl, n-, i-, sec.- or tert.- Butyl, methoxy, ethoxy, n- or i-propoxy, methylthio, ethylthio, n- or i-propylthio, trifluoromethyl, difluoromethoxy, trifluoromethoxy, acetyl, ethylcarbonyl and / or phenyl, which itself can be substituted once or twice, identically or differently by fluorine, chlorine, methyl and / or ethyl.
  • Methoximinoethyl or ethoximinoethyl each simply up to fourfold, identical or different by fluorine, chlorine, methyl or ethyl substituted methylenedioxy or ethylenedioxy, and in each case optionally in the phenyl part simply to fourfold identical or different by fluorine, chlorine, bromine, cyano, methyl, ethyl, n- or i-propyl , n-, i-, s- or t-butyl, trifluoromethyl, methoxy, ethoxy, n- or i-propoxy, difluoromethoxy or
  • R very particularly preferably represents hydrogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, sec-butyl, tert-butyl; for chloromethyl, bromomethyl, chloroethyl, bromoethyl, chloropropyl, bromopropyl; for methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl; for cyclopropyl optionally substituted one to four times, identically or differently by fluorine, chlorine, bromine, methyl, ethyl, n- or i-propyl, chloromethyl dichloromethyl and / or trifluoromethyl
  • a preferred group of compounds according to the invention are 2-imidazolidinone derivatives of the formula in which
  • R represents phenyl which is monosubstituted to trisubstituted in the same way or differently, the substituents which may be mentioned as preferred, particularly preferred or very particularly preferred phenyl substituents in connection with the description of R 1 and
  • R, R 4 and R 5 have the abovementioned general, preferred, particularly preferred or very particularly preferred meanings.
  • R 10 represents phenyl which is monosubstituted to trisubstituted in the same way or differently, the substituents which may be mentioned as preferred, particularly preferred or very particularly preferred in connection with the description of R 1 and
  • R 2 , R 6 and R 7 have the abovementioned general, preferred, particularly preferred or very particularly preferred meanings.
  • Another group of preferred compounds according to the invention are 2-imidazolidinone derivatives of the formula
  • R 10 represents phenyl which is monosubstituted to trisubstituted in the same way or differently, the substituents which may be mentioned as preferred, particularly preferred or very particularly preferred in connection with the description of R 1 and
  • R and R have the abovementioned general, preferred, particularly preferred or very particularly preferred meanings.
  • R 11 stands for phenyl, pyridinyl or pyrimidinyl which is optionally monosubstituted to trisubstituted in the same way or differently, the substituents which are preferred, particularly preferred or very particularly preferred for these radicals in connection with the description of R and
  • R 1 , R 4 and R 5 have the abovementioned general, preferred, particularly preferred or very particularly preferred meanings.
  • Another group of preferred compounds according to the invention are 2-imidazolidinone derivatives of the formula
  • R n represents phenyl, pyridinyl or pyrimidinyl which may be mono- to trisubstituted in the same way or differently, the substituents which may be mentioned as preferred, particularly preferred or very particularly preferred for these radicals in connection with the description of R 2 and
  • R, R and R have the abovementioned general, preferred, particularly preferred or very particularly preferred meanings.
  • R n represents phenyl, pyridinyl or pyrimidinyl which may be mono- to trisubstituted in the same way or differently, the substituents which may be mentioned as preferred, particularly preferred or very particularly preferred for these radicals in connection with the description of R 2 and R 1 and R 8 have the abovementioned general, preferred, particularly preferred or very particularly preferred meanings.
  • hydrocarbon radicals mentioned above in the definition of the compounds according to the invention are in each case straight-chain or branched, to the extent possible, even in conjunction with other atoms, such as haloalkyl.
  • radical definitions can be combined with one another, that is to say also between the specified ranges of preferred compounds.
  • reaction sequence of process (a) according to the invention can be represented by the following formula:
  • reaction sequence of process (b) according to the invention can be represented by the following formula:
  • Formula (II) provides a general definition of the 2-imidazolidinones required as starting materials for carrying out processes (a) and (c) according to the invention.
  • R 1 and R 2 preferably or particularly preferably have those meanings which are preferred or particularly preferred in connection with the description of the compounds of the formula (I) were preferably given for R 1 and R 2 .
  • the 2-imidazolidinones of Fo ⁇ nel (II) are contagious (see e.g. CA 118 (11). 101 978k; CA Ü4_ (1 1), 101 824z; CA 109 (15), 129 006e; CA 107 (17), 154 281g or CA 9J. (19), 157 661t) or in analogy to known processes, for example by Urea derivatives of the formula
  • R 1 and R 2 have the meaning given above
  • urea derivatives of the formula (VI) are known (see, for example, Zh. Org. Khim (Engl. Transl.) 15, 1077 (1979) or ü, 2407 (1975) or ⁇ 2, 522 (1976)) respectively. available in analogy to the processes described there (see also the preparation examples).
  • ethylenediamines of the formula (VII) are known (cf., for example, J. Org. Chem. 56, 5192 (1991) or Synthesis 1992. 664 or Helv. Chim. Acta 53, 47 (1970) or Synthesis 1993. 1013 or J. Chem. Soc, Perkin Trans. 2, 1981, 317) or in
  • Formula (Ula) provides a general definition of the isocyanates required as reaction components for carrying out process (a) according to the invention.
  • R 5 preferably or particularly preferably has those meanings which have already been given as preferred or particularly preferred for R in connection with the description of the compounds of the formula (I).
  • the isocyanates of the formula (IHa) are known or can be prepared by known processes.
  • Formula (DTb) provides a general definition of the isothiocyanates required as reaction components for carrying out process (a) according to the invention.
  • R preferably or particularly preferably has those meanings which have already been given as preferred or particularly preferred for R 7 in connection with the description of the compounds of the formula (I).
  • the isothiocyanates of the formula (Hlb) are known or can be prepared by known methods.
  • the formulas (Ia) and (Ib) generally define the 2-imidazolidinone derivatives required as starting materials for carrying out process (b) according to the invention.
  • R 1 , R 2 , R 5 and R 7 preferably or particularly preferably have those meanings which are preferred or particularly preferred in connection with the description of the compounds of the formula (I) were preferably given for R 1 , R 2 , R 5 and R 7 .
  • Formula (IV) provides a general definition of the compounds required as reaction components when carrying out process (b) according to the invention.
  • R 9 preferably or particularly preferably has those meanings which have already been given as preferred or particularly preferred for the radical R 4 in connection with the description of the compounds of the formula (I) were.
  • Y is preferably hydroxyl, methoxy, acetoxy, chlorine, bromine, iodine, trimethylammonium, phenylsulfonyl, p-tolylsulfonyl or 4-chlorophenylsulfonyl.
  • the compounds of the formula (IV) are known or can be prepared by known methods.
  • Formula (V) provides a general definition of the sulfonyl derivatives required as reaction components when carrying out process (c) according to the invention.
  • R 8 preferably or particularly preferably has those meanings which have already been associated with the description of the
  • Z preferably represents chlorine or bromine.
  • R 1 , R 2 , R 6 and R 7 have the meanings given above,
  • R 1 , R 2 , R 4 and R 5 have the meanings given above,
  • a sulfurizing agent such as P 4 S ] 0 or Lawesson's reagent [2,4-bis- (4-methoxyphenyl) -l, 3,2,4-dithiaphosphetane-2,4-dithione], optionally in the presence a diluent, such as xylene or toluene, at temperatures between 80 ° C and 200 ° C.
  • Inert organic solvents are suitable as diluents when carrying out process (a) according to the invention.
  • Aliphatic, alicyclic or aromatic, optionally halogenated can preferably be used
  • Hydrocarbons such as gasoline, benzene, toluene, xylene, chlorobenzene, dichlorobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, chloroform, carbon tetrachloride, ethers, such as diethyl ether, diisopropyl ether, dioxane, tetrahydrofuran or ethylene glycol dimethyl or nitrile diethyl ether such as acetonitrile, propionitrile or benzonitrile; Amides, such as N, N-dimethylformamide,
  • Suitable acid binders for carrying out process (a) according to the invention are all customary inorganic and organic bases.
  • Alkaline earth metal or alkali metal hydrides, hydroxides, amides, alcoholates, acetates, carbonates or hydrogen carbonates such as, for example, sodium hydride, sodium amide, sodium methylate, sodium ethylate, potassium tert-butoxide, sodium hydroxide, potassium hydroxide, sodium acetate, potassium acetate, can preferably be used , Calcium acetate, ammonium acetate, sodium carbonate, potassium carbonate, potassium hydrogen carbonate, sodium hydrogen carbonate, furthermore ammonium hydroxide or ammonium carbonate, and also tertiary amines, such as trimethylamine, triethylamine, tributylamine, N, N-dimethylaniline, pyridine, N-methylpiperidine, N, N-dimethyl aminopyridine, diazabicyclooctane (DABCO), diaza
  • reaction temperatures can be varied within a substantial range when carrying out process (a) according to the invention. In general, temperatures between -30 ° C and + 100 ° C, preferably at temperatures between -20 ° C and + 60 ° C.
  • Process (a) according to the invention is usually carried out under normal pressure. However, it is also possible to work under increased or reduced pressure.
  • Inert organic solvents are suitable as diluents for carrying out process (b) according to the invention.
  • Aliphatic, alicyclic or aromatic, optionally halogenated hydrocarbons such as, for example, gasoline, benzene, toluene, xylene, chlorobenzene, dichlorobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, chloroform or carbon tetrachloride can preferably be used; Ethers such as diethyl ether, diisopropyl ether, dioxane, tetrahydrofuran or ethylene glycol dimethyl or diethyl ether; Ketones such as acetone or butanone or methyl isobutyl ketone; Nitriles such as acetonitrile, propionitrile or benzonitrile; Amides such as N, N-dimethylformamide, N, N-dimethylacetamide, N-methylf
  • Water can be used as a diluent.
  • Reaction aids are useful when carrying out the process according to the invention.
  • Process (b) all conventional inorganic and organic bases into consideration. All those acid binders which have already been mentioned as preferred acid binders in connection with the description of process (a) according to the invention can preferably be used.
  • reaction temperatures can be carried out when carrying out the process according to the invention.
  • Process (b) can be varied over a wide range. In general, temperatures between 0 ° C and 150 ° C, preferably at temperatures between 40 ° C and 100 ° C.
  • 1.0 to 5.0 mol, preferably 1.0 to 2.5 mol, of compound of the compound are generally employed per mol of 2-imidazolidinone derivative of the formula (Ia) or (Ib) Formula (IV) and optionally 1.0 to 5.0 mol, preferably 1.0 to 2.5 mol, of reaction auxiliary.
  • Inert organic solvents are suitable as diluents for carrying out process (c) according to the invention.
  • Aliphatic, alicyclic or aromatic, optionally halogenated hydrocarbons such as, for example, gasoline, benzene, toluene, xylene, chlorobenzene, dichlorobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, chloroform or carbon tetrachloride can preferably be used;
  • Ethers such as diethyl ether, diisopropyl ether, dioxane, tetrahydrofuran or ethylene glycol dimethyl or diethyl ether, ketones such as acetone or butanone or methyl isobutyl ketone; Nitriles such as acetonitrile, propionitrile or benzonitrile or esters such as methyl acetate or ethyl acetate.
  • Process (c) according to the invention is preferably carried out in the presence of a suitable acid binder.
  • All conventional inorganic or organic bases are suitable as such.
  • Alkaline earth metal or alkali metal hydroxides such as sodium hydroxide, calcium hydroxide, potassium hydroxide or also ammonium hydroxide, alkali metal carbonates such as sodium carbonate, potassium carbonate, potassium hydrogen carbonate, sodium hydrogen carbonate, alkali metal or alkaline earth metal acetates, such as sodium acetate, are preferably usable.
  • Potassium carbonate, calcium acetate and tertiary amines such as trimethylamine, triethylamine, tributylamine, N, N-dimethylaniline, pyridine, N-methylpiperidine, N, N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclonones (DBN) or diazabicycloundecen (DBU).
  • reaction temperatures can be varied within a substantial range when carrying out process (c) according to the invention. In general, temperatures between 0 and 150 ° C, preferably at temperatures between 20 and 120 ° C.
  • Process (c) according to the invention is usually carried out under normal pressure. However, it is also possible to increase or decrease it
  • 1.0 to 2.0 mol, preferably 1.0 to 1.3 mol, of sulfonyl derivative of the formula (V) are generally employed per mol of 2-imidazolidinone of the formula (II) and optionally 1.0 to 2.0 moles, preferably 1.0 to 1.3 moles, of acid binder.
  • reaction products are worked up and isolated by known processes.
  • the active compounds according to the invention have a strong microbicidal action and can be used practically to combat unwanted microorganisms.
  • the active ingredients are suitable for use as crop protection agents, in particular as fungicides.
  • Fungicidal agents in crop protection are used to combat Pias ⁇ modes ophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes, Deuteromycetes.
  • pathogens of fungal diseases which come under the generic names listed above may be mentioned as examples, but not by way of limitation: Pythium species, such as, for example, Pythium ultimum; Phytophthora species, such as, for example, Phytophthora infestans; Pseudoperonospora species, such as, for example, Pseudoperonospora humuli or Pseudoperonospora cubensis;
  • Plasmopara species such as, for example, Plasmopara viticola
  • Peronospora species such as, for example, Peronospora pisi or Peronospora brassicae
  • Erysiphe species such as, for example, Erysiphe graminis
  • Sphaerotheca species such as, for example, Sphaerotheca fuliginea
  • Podosphaera species such as, for example, Podosphaera leucotricha
  • Venturia species such as, for example, Venturia inaequalis
  • Pyrenophora species such as, for example, Pyrenophora teres or Pyrenophora graminea (conidial form: Drechslera, synonym: Helminthosporium);
  • Cochliobolus species such as, for example, Cochliobolus sativus (conidial form: Drechslera, synonym: Helminthosporium);
  • Uromyces species such as, for example, Uromyces appendiculatus
  • Puccinia species such as, for example, Puccinia recondita
  • Tilletia species such as, for example, Tilletia caries
  • Ustilago species such as, for example, Ustilago nuda or Ustilago avenae
  • Pellicularia species such as, for example, Pellicularia sasakii
  • Pyricularia species such as, for example, Pyricularia oryzae
  • Fusarium species such as, for example, Fusarium culmorum
  • Botrytis species such as, for example, Botrytis cinerea
  • Septoria species such as, for example, Septoria nodorum
  • Leptosphaeria species such as, for example, Leptosphaeria nodorum
  • Cercospora species such as, for example, Cercospora canescens
  • Alternaria species such as, for example, Alternaria brassicae;
  • Pseudocercosporella species such as, for example, Pseudocercosporella herpotrichoides.
  • the active compounds according to the invention can be used with particularly good success for combating diseases in fruit and vegetable cultivation, for example against Podosphaera and Uncinula species, and for combating cereal diseases, for example for Erysiphe and Septoria species.
  • the active compounds can be converted into customary formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols, very fine encapsulations in polymeric substances and in coating compositions for seeds, as well as ULV cold and warm mist formulations.
  • formulations are made in a known manner, e.g. by mixing the active ingredients with extenders, that is to say liquid solvents, pressurized liquefied gases and / or solid carriers, if appropriate using surface-active agents, that is to say emulsifiers and / or dispersants and / or foam-generating agents. If water is used as an extender, e.g. organic solvents can also be used as auxiliary solvents.
  • extenders that is to say liquid solvents, pressurized liquefied gases and / or solid carriers, if appropriate using surface-active agents, that is to say emulsifiers and / or dispersants and / or foam-generating agents.
  • surface-active agents that is to say emulsifiers and / or dispersants and / or foam-generating agents.
  • water e.g. organic solvents can also be used as auxiliary solvents.
  • aromatics such as xylene, toluene, alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons, such as chlorobenzenes, chlorethylenes, or methylene chloride
  • aliphatic hydrocarbons such as cyclohexane or paraffins, e.g. Petroleum fractions, alcohols, such as butanol or glycol, and their ethers and esters, ketones, such as acetone, methyl ethyl ketone,
  • liquefied gaseous extenders or carriers mean liquids which are gaseous at normal temperature and under normal pressure, e.g. Aerosol propellants, such as halogenated hydrocarbons and butane, propane, nitrogen and carbon dioxide;
  • solid carriers are possible: e.g. natural rock powders such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth and synthetic rock powders, such as highly disperse silica, aluminum oxide and silicates;
  • Solid carriers for granules are possible: e.g. broken and fractionated natural rocks such as calcite,
  • emulsifying and / or foaming agents are possible: e.g. non-ionic and anionic emulsifiers such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ether, e.g. Alkylaryl polyglycol ethers, alkyl sulfonates, alkyl sulfates, aryl sulfonates and protein hydrolyzates; Possible dispersants are: e.g. Lignin sulfite liquor and methyl cellulose.
  • Adhesives such as carboxymethyl cellulose, natural and synthetic, powdery, granular or latex-shaped polymers can be used in the formulations are used, such as gum arabic, polyvinyl alcohol, polyvinyl acetate, and natural phospholipids, such as cephalins and lecithins and synthetic phospholipids.
  • Other additives can be mineral and vegetable oils.
  • Dyes such as inorganic pigments, e.g. Iron oxide, titanium oxide, ferrocyan blue and organic dyes such as alizarin, azo and
  • Metal phthalocyanine dyes and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc can be used.
  • the formulations generally contain between 0.1 and 95 percent by weight of active compound, preferably between 0.5 and 90%.
  • the active compounds according to the invention can also be used in a mixture with known fungicides, bactericides, acaricides, nematicides or insecticides, in order, for example, to broaden the spectrum of activity or to prevent the development of resistance.
  • synergistic effects occur, i.e. the effectiveness of the mixture is higher than the effectiveness of the individual components.
  • Fenarimol, Fenbuconazole, Fen Inenarimol, Fenbuconazole, Fen Nameam, Fenitropan, Fenpiclonil, Fenpropidin, Fen-propimorph, Fentinacetat, Fentinhydroxyd, Ferbam, Ferimzone, Fluazinam, Fludioxonil, Fluoromide, Fluquinconazole, Flusilazole, Flusulfamide, Flutolanyl, Folutolafil, Fuberri Furalaxyl,
  • Tebuconazole Tebuconazole, tecloftalam, tecnazene, tetraconazole, thiabendazole, Thicyofen, thiophanate-methyl, thiram, Tolclophos-methyl, tolylfluanid, triadimefon, triadimenol, triazoxide, Trichlamid, tricyclazole, tridemorph, triflumizole, triforine, triticonazole,
  • Cadusafos Carbaryl, Carbofuran, Carbophenothion, Carbosulfan, Cartap,
  • Chloethocarb Chlorethoxyfos, Chloretoxyfos, Chlorfenvinphos, Chlorfluazuron,
  • Chlormephos N - [(6-chloro-3-pyridinyl) methyl] -N'-cyano-N-methylethanimidamide, chlorpyrifos, chlorpyrifos M, cis-resmethrin, clocythrin, clofentezine, cyanophos, cycloprothrin, cyfluthrin, Cyhalothrin, cyhexatin,
  • Fenamiphos Fenazaquin, Fenbutatinoxid, Fenitrothion, Fenobucarb, Fenothiocarb, Fenoxycarb, Fenpropathrin, Fenpyrad, Fenpyroximat, Fenthion, Fenvalerate,
  • Fipronil fluazinam, fluazuron, flucycloxuron, flucythrinate, flufenoxuron,
  • Flufenprox Fluvalinate, Fonophos, Formothion, Fosthiazat, Fubfenprox,
  • HCH Heptenophos, Hexaflumuron, Hexythiazox, Imidacloprid, Iprobefos, Isazophos, Isofenphos, Isoprocarb, Isoxathion, Ivemectin,
  • Methamidophos methidathione, methiocarb, methomyl, metolcarb, milbemectin,
  • Parathion A Parathion M, Permethrin, Phenthoat, Phorat, Phosalon, Phosmet,
  • Tebufenozide Tebufenpyrad
  • Tebupirimiphos Teflubenzuron
  • Tefluthrin Temephos
  • Terbam Terbufos
  • Tetrachlorvinphos Thiafenox, Thiodicarb
  • Triazophos triazuron, trichlorfon, triflumuron, trimethacarb, Vamidothione, XMC, xylylcarb, zetamethrin.
  • the active compounds can be used as such, in the form of their formulations or the use forms prepared therefrom, such as ready-to-use solutions, suspensions, wettable powders, pastes, soluble powders, dusts and granules. They are used in the usual way, e.g. by pouring, spraying, atomizing, scattering, dusting, foaming, brushing, etc. It is also possible to apply the active ingredients by the ultra-low-volume process or to inject the active ingredient preparation or the active ingredient into the soil itself. The seeds of the plants can also be treated.
  • the active compound concentrations in the use forms can be varied within a substantial range. They are generally between 1 and 0.0001% by weight, preferably between 0.5 and 0.001% by weight.
  • amounts of active ingredient of 0.001 to 50 g per kilogram of seed, preferably 0.01 to 10 g, are generally required.
  • active ingredient concentrations of 0.00001 to 0.1% by weight, preferably 0.0001 to 0.02% by weight, are required at the site of action.
  • Toluene is refluxed for 6 hours on a water separator. It is then concentrated.
  • Solvent 4.7 parts by weight of acetone emulsifier: 0.3 part by weight of alkyl aryl polyglycol ether
  • active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration.
  • the plants are then placed in a greenhouse at 23 to 24 ° C and at a relative humidity of approx. 75%.
  • Evaluation is carried out 14 days after the inoculation.
  • Emulsifier 0.3 part by weight of alkyl aryl polyglycol ether
  • active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration.
  • the plants are then placed in a greenhouse at 23 ° C. and a relative atmospheric humidity of approx. 70%.
  • Evaluation is carried out 10 days after the inoculation.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP95926914A 1994-07-28 1995-07-17 2-imidazolidinon-derivate als fungizide Withdrawn EP0772599A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4426757 1994-07-28
DE19944426757 DE4426757A1 (de) 1994-07-28 1994-07-28 2-Imidazolidinon-Derivate
PCT/EP1995/002800 WO1996003386A1 (de) 1994-07-28 1995-07-17 2-imidazolidinon-derivate als fungizide

Publications (1)

Publication Number Publication Date
EP0772599A1 true EP0772599A1 (de) 1997-05-14

Family

ID=6524369

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95926914A Withdrawn EP0772599A1 (de) 1994-07-28 1995-07-17 2-imidazolidinon-derivate als fungizide

Country Status (5)

Country Link
EP (1) EP0772599A1 (ja)
JP (1) JPH10502934A (ja)
AU (1) AU3112895A (ja)
DE (1) DE4426757A1 (ja)
WO (1) WO1996003386A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125432A1 (de) * 2001-05-25 2002-11-28 Bayer Ag Substituierte Benzoylketone
TW200831080A (en) * 2006-12-15 2008-08-01 Irm Llc Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
EP2679585A4 (en) * 2011-02-21 2014-08-06 Taisho Pharmaceutical Co Ltd TRANSPORT INHIBITOR OF GLYCINE
DE102021002823A1 (de) 2021-06-01 2022-12-01 Messer Se & Co. Kgaa Verfahren und Vorrichtung zum Pressen eines flüssigen Extrakts aus einem Pressgut

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3823240A (en) * 1970-10-06 1974-07-09 Rhone Poulenc Sa Fungicidal hydantoin derivatives
CH592653A5 (ja) * 1973-09-24 1977-10-31 Ciba Geigy Ag
JPS58206569A (ja) * 1982-05-26 1983-12-01 Otsuka Chem Co Ltd イミダゾリジン−2−オン誘導体

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9603386A1 *

Also Published As

Publication number Publication date
AU3112895A (en) 1996-02-22
JPH10502934A (ja) 1998-03-17
DE4426757A1 (de) 1996-02-01
WO1996003386A1 (de) 1996-02-08

Similar Documents

Publication Publication Date Title
EP0712396B1 (de) Substituierte azadioxacycloalkene und ihre verwendung als fungizide
DE4443641A1 (de) Substituierte Carbonsäureamide
EP0828738B1 (de) Pyridyl-thiazole und deren verwendung zum schutz von pflanzen gegen befall durch mikroorganismen
EP0730583B1 (de) 3-methoxy-2-phenyl-acrylsäuremethylester
EP0623604B1 (de) Oxa(Thia)-diazol-oxy-phenyl-acrylate als Schädlingsbekämpfungsmittel
EP0749419B1 (de) Oxim-derivate und ihre verwendung als schädlingsbekämpfungsmittel
DE4408005A1 (de) Substituierte Azadioxacycloalkene
EP0809637B1 (de) Fungizide aza-heterocycloalkene
EP0772599A1 (de) 2-imidazolidinon-derivate als fungizide
EP0865423B1 (de) Iminoessigsäureamide und ihre verwendung als schädlingsbekämpfungsmittel
WO1997000856A1 (de) Carbonsäureamidderivate und ihre verwendung als schädlingsbekämpfungsmittel
EP0863886B1 (de) Fluormethoxyacrylsäurederivate und ihre verwendung als schädlingsbekämpfungsmittel
DE4419587A1 (de) Heterocyclische Imino-Derivate
EP0707578A1 (de) 2-oximino-2-thienyl-essigsäurederivate
EP0820436B1 (de) Substituierte cycloalkene und ihre verwendung als mikrobizide, insbesondere als fungizide
EP0772587B1 (de) N-alkoxy-amidin-derivate und deren verwendung als schädlingsbekämpfungsmittel
EP0820437A1 (de) Hydrazonoessigsäureamide und ihre verwendung als schädlingsbekämpfungsmittel
WO1995021833A1 (de) Substituierte oxazacycloalkene, zwischenprodukte und verwendung als fungizide
EP0741695A1 (de) Hydroxamsäurederivate, verfahren zu ihrer herstellung und verwendung als fungizide
WO1996017835A1 (de) Fungizide 1,3,4-oxathiazol-2-one
DE19611653A1 (de) Fluormethoxyacrylsäurederivate
EP0767784A1 (de) Pyridin-3-imino-alkylester als fungizide
DE19508573A1 (de) Imidsäurederivate
DE19510297A1 (de) Substituierte Heterocycloalkene
DE19547633A1 (de) Heteroarylcarbonsäureamide

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961218

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE ES FR GB IT LI NL

17Q First examination report despatched

Effective date: 19991008

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000219